The results of this study have demonstrated the efficacy of EC359 in inhibiting the LIFR pathway and have established a critical function of LIFR signaling in mediating the effects of obesity on TNBC progression. This evidence concerns the gene LIFR and obesity due to melanocortin 4 receptor deficiency.